日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Ruxolitinib for the treatment of steroid-refractory acute GVHD (REACH1): a multicenter, open-label phase 2 trial

鲁索替尼治疗类固醇难治性急性移植物抗宿主病（REACH1）：一项多中心、开放标签的 II 期试验

期刊:Blood
影响因子:23.1
doi:10.1182/blood.2020004823
Jagasia, Madan; Perales, Miguel-Angel; Schroeder, Mark A; Ali, Haris; Shah, Nirav N; Chen, Yi-Bin; Fazal, Salman; Dawkins, Fitzroy W; Arbushites, Michael C; Tian, Chuan; Connelly-Smith, Laura; Howell, Michael D; Khoury, H Jean
发表日期：2020
文献求助 收藏

Screening for iron overload: lessons from the hemochromatosis and iron overload screening (HEIRS) study

铁过载筛查：来自血色素沉着症和铁过载筛查（HEIRS）研究的启示

期刊:Canadian Journal of Gastroenterology
影响因子:2.3
doi:10.1155/2009/839308
Adams, Paul; Barton, James C; McLaren, Gordon D; Acton, Ronald T; Speechley, Mark; McLaren, Christine E; Reboussin, David M; Leiendecker-Foster, Catherine; Harris, Emily L; Snively, Beverly M; Vogt, Thomas; Sholinsky, Phyliss; Thomson, Elizabeth; Dawkins, Fitzroy W; Gordeuk, Victor R; Eckfeldt, John H
发表日期：2009
文献求助 收藏

Clinical manifestations of hemochromatosis in HFE C282Y homozygotes identified by screening

通过筛查发现HFE C282Y纯合子血色素沉着症的临床表现

期刊:Canadian Journal of Gastroenterology
影响因子:2.3
doi:10.1155/2008/907356
McLaren, Gordon D; McLaren, Christine E; Adams, Paul C; Barton, James C; Reboussin, David M; Gordeuk, Victor R; Acton, Ronald T; Harris, Emily L; Speechley, Mark R; Sholinsky, Phyliss; Dawkins, Fitzroy W; Snively, Beverly M; Vogt, Thomas M; Eckfeldt, John H
发表日期：2008
文献求助 收藏